Journal of ISSN: 2373-4426JPNC

Pediatrics & Neonatal Care
Editorial
Volume 2 Issue 4 - 2015
Universal Pulse Oximetry Screening for Critical Congenital Heart Disease in Asymptomatic Newborns
Adel Zauk1,2*
1Chief of Neonatology and Director of Nurseries, St. Joseph’s Children’s Hospital, USA
2Adjunct Associate Professor of Pediatrics, New York Medical College, USA
Received: April 10, 2015| Published: August 27, 2015
*Corresponding author: Adel Zauk, Chief of Neonatology and Director of Nurseries, St. Joseph’s Children’s Hospital, Adjunct Associate Professor of Pediatrics, New York Medical College, New York, USA, Email: @
Citation: Zauk A (2015) Universal Pulse Oximetry Screening for Critical Congenital Heart Disease in Asymptomatic Newborns. J Pediatr Neonatal Care 2(4): 00085. DOI: 10.15406/jpnc.2015.02.00085

Editorial

Heart defects are one of the leading causes of infant mortality in the western world. However, some babies who have critical congenital heart defects (CCHDs) are born asymptomatic. Newborn screening using pulse oximetry prior to hospital discharge has been shown to be effective for identifying infants with CCHDs [1]. The seven main CCHDs screening targets are: Hypoplastic left heart syndrome, Pulmonary Atresia (with intact ventricular septum), Tetralogy of Fallot, Total Anomalous Pulmonary Venous Return, Transposition of the Great Arteries, Tricuspid Atresia and Truncus Arteriosus. Infants with these conditions require interventional cardiac catherization or surgery within the first few months of life. Early diagnosis of CCHDs improves health outcomes and reduces health care costs [2].

New Jersey was the first state to recognize the importance of screening newborns for CCHDs after the first 24 hours of life [3]. The New Jersey protocol requires both pre-ductal (right hand) and post-ductal (either foot) measured oxygen saturations to be 95% or higher. Any infant who fails the pulse oximetry screen should have a diagnostic echocardiogram. In June 2011, New Jersey passed a law requiring pulse oximetry screening in all licensed birthing facilities. Soon after, the Department of Health developed a screening algorithm that specified pre and post-ductal screening between 24 and 48 hours of life or prior to hospital discharge. In September 2011, Kathleen Sebelius, the US Secretary of Health and Human Services, recommended that all states add pulse oximetry screening for CCHDs to the uniform screening panel for newborns. Subsequently, the American Academy of Pediatrics published a policy statement endorsing the Health and Human Services’ recommendation [4]. The American College of Cardiology Foundation and the American Heart Association recommended that screening should be done no earlier than 24 hours of life and before hospital discharge. Many states are moving toward legislation mandating all birthing centers and hospitals to screen for CCHDs. Today, many hospitals in the US have voluntarily initiated routine pulse oximetry screening for CCHDs in asymptomatic newborns.

Pulse oximetry screening for CCHDs in newborns has already been legislated in several European countries and in many states in the US. Noninvasive oxygen monitoring is painless, simple, inexpensive and readily available [5]. The time has come that all hospitals and birthing centers worldwide should implement routine screening for CCHDs using pulse oximetry.

References

  1. Koppel RI, Druschel CM, Carter T, Goldberg BE, Mehta PN, et al. (2003) Effectiveness of pulse oximetry screening for congenital heath disease in asymptomatic newborns. Pediatrics 111(3): 451-455.
  2. Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, et al. (2013) Temporal trends in survival for infants with critical congenital heart defects. Pediatrics 131(5): e1502-e1508.
  3. Garg LF, Van Naarden Braun K, Knapp MM, Anderson TM, Koppel RI, et al. (2013) Results from the New Jersey statewide critical congenital heart defects screening program. Pediatrics 132(2): e314-e323.
  4. Mahle WT, Martin GR, Beekman RH 3rd, Morrow WR (2012) Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 129(1): 190-192.
  5. Ewer AK (2013) Review of pulse oximetry screening for critical congenital heart defects in newborn infants. Curr Opin Cardiol 28(2): 92-96.
© 2014-2016 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://medcraveonline.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy